Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gossamer Bio Inc (NQ: GOSS )

1.190 -0.020 (-1.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,369,047
Open 1.190
Bid (Size) 1.160 (50)
Ask (Size) 1.260 (1)
Prev. Close 1.210
Today's Range 1.140 - 1.225
52wk Range 0.9600 - 15.20
Shares Outstanding 75,993,532
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga

Performance

YTD
-41.67%
-41.67%
1 Month
-39.29%
-39.29%
3 Month
-42.79%
-42.79%
6 Month
-91.25%
-91.25%
1 Year
-86.40%
-86.40%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Where Gossamer Bio Stands With Analysts
Via Benzinga
Barclays Downgrades Gossamer Bio: Here's What You Need To Know
Via Benzinga
Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update
From Gossamer Bio, Inc.
Via Business Wire
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
What 9 Analyst Ratings Have To Say About Gossamer Bio
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Via Benzinga
7 Top Short-Squeeze Candidates to Watch in February
Via InvestorPlace
Looking Into Gossamer Bio's Recent Short Interest
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
Via Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday
Via Benzinga
Dow Dips Over 500 Points; Nasdaq Down 2.5%
Via Benzinga
Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.